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Elective treatment of abdominal aortic aneurysm
with endovascular or open repair: The first decade
Santiago Chahwan, MD,a Anthony J. Comerota, MD,a John P. Pigott, MD,a Barry W. Scheuermann, PhD,a
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Objectives: The development of endovascular aneurysm repair (EVAR) as an alternative to open repair of abdominal aortic
aneurysms (AAA) has led to an increasing number of patients being treated by this less-invasive technique. It was
anticipated that EVAR would reduce the operative mortality and morbidity compared with open repair. This study
examined the initial 10-year experience in one center when both techniques were available to determine if there were
advantages to one technique or the other, putting the results into the perspective of routine clinical care of patients with
infrarenal AAA.
Methods: From June 1996 toMay 2005, 677 patients underwent elective repair of their infrarenal AAA, of which 417were
treated with open repair and 260 by EVAR. Demographic and aneurysm-specific data, comorbidities, operative
morbidity, mortality, and late outcome were analyzed.
Results: Open repair patients were 2 years younger (71 vs 74 years, P < .001), had larger aneurysms (6.01  1.38 cm vs
5.45 0.99 cm, P< .001), greater familial predisposition, a higher incidence of current smokers, and a higher incidence
of chronic obstructive pulmonary disease than the EVAR group. There were no differences in renal function, hyperten-
sion, coronary artery disease, or heart failure between the two groups. Overall operative mortality was 3.1%; operative
mortality per group was 3.5% for open and 2.7% for EVAR (P  .627). Procedure-related outcomes showed significant
differences in operative blood loss and length of hospital stay in favor of EVAR, and 95% of the EVAR patients were
discharged home vs 83% in the open repair group (P < .001). A Kaplan-Meier log-rank analysis showed no difference in
early or long-term survival between open repair and EVAR (P  .20), but did show a difference in mid-term (3-year)
survival favoring open repair (P < .002). Survival analysis by age (<70 and >70 years) showed no difference between
treatment groups.
Conclusions:Open repair and EVAR are both performed safely in patients treated for elective infrarenal AAA. EVAR has
the perioperative advantages of reduced blood loss, reduced length of intensive care unit and hospital stay, and increased
number of patients discharged to home. The mid-term survival advantage of open repair has been observed in other
reports and deserves further study. (J Vasc Surg 2007;45:258-62.)The past decade has brought about a major change in
the approach to patients with aortic aneurysms. The ongo-
ing enthusiasm to find less-invasive means of managing all
forms of vascular disease has resulted in the evolution of
catheter-based techniques that can be applied to every
major vascular bed.
Open repair of abdominal aortic aneurysms (AAA) has
always been considered among the most major of surgical
procedures, and the potential complications, which are
decreasing in frequency, are highly morbid. It is not sur-
prising that endovascular aneurysm repair (EVAR) was a
welcome addition to the procedural armamentarium of the
vascular surgeon. Vascular disease, however, is a lifelong
problem and most often associated with significant comor-
bidities that frequently will determine the outcome of
major vascular reconstructions.
Unquestionably, operative management has improved,
and the advances in critical care have reduced operative
morbidity and mortality. EVAR has reduced the need for
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258intensive care unit stay and blood transfusions, shortened
hospital stays, and in some studies, decreased procedure-
related and aneurysm-related mortality.1,2 The reduction
in operative mortality observed in randomized trials has not
been observed in all studies, however, and has not yet
translated into better survival during longer term follow-up.
Many centers became involved with EVAR as part of
registration trials for new devices. Such trials had specific
guidelines for graft implantations. Once devices received
United States Food and Drug Administration approval,
guidelines for use continued but physician judgment be-
came more prominent in patient selection.
During the last 10 years, the Jobst Vascular Center has
offered endovascular and open repair to patients undergo-
ing elective treatment of their infrarenal AAA. This study
reviewed the procedure-related morbidity and mortality of
open and EVAR and investigated the effect of these proce-
dures on mid-term and long-term survival.
PATIENTS AND METHODS
All patients undergoing elective repair of an infrarenal
AAA between June 1996 and May 2005 were reviewed.
Patients were identified from the Jobst Vascular Registry,
which prospectively records patients undergoing vascular
procedures at The Toledo Hospital. The operating room
database and individual surgeon case lists were also used to
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information were recorded from these databases in addition
to lab records, operative notes, physician notes, and radiol-
ogy records. The study was approved by the hospital’s
Institutional Review Board.
Patients with ruptured aneurysms or aneurysms involv-
ing the renal arteries were excluded from this analysis.
Elective repair of infrarenal AAA was performed in 677
consecutive patients. The type of repair was decided by the
primary vascular surgeon and patient preference. Devices
used for the EVAR group included EVT (Endovascular
Technologies, Menlo Park, Calif), Vanguard (Boston Sci-
entific, Natick, Mass), Lifepath (Baxter, Morton Grove,
Ill), Lifepath (Edwards, Irvine, Calif), Zenith (Cook,
Bloomington, Ind), Talent and AneuRx (Medtronic, Santa
Rosa, Calif), AnCure (Guidant, Indianapolis, Ind), and
Excluder (W. L. Gore & Associates, Flagstaff, Ariz).
Computed tomography (CT) scans and arteriography
were obtained in nearly every case of EVAR early in the
experience and evolved to CT scans alone as the sole
imaging method during the latter part of the study. CT
scans were the predominant imaging method for patients
having open repair.
Main outcome measures were operative death (defined
as death 30 days of the procedure or during the same
hospitalization, whichever was longer), blood loss, length
of hospital stay, status at discharge, and long-term mortal-
ity.
The EVAR group was monitored with physical exami-
nation and serial CT scans and plain abdominal radiographs
at 1, 6, 12, 18, and 24 months, and yearly thereafter.
Patients in the open repair group were monitored at 1, 6,
and 12 months with physical examination and generally
every 6 to 12months thereafter. Postoperative imaging was
not routinely performed in patients having open repair.
Follow-up data were retrieved from the hospital database,
the inpatient and outpatient data systems, and the Social
Security Registry.
Statistical analysis. Cumulative event rates were de-
termined with Kaplan-Meier survival analysis, and the
probability difference between patients undergoing open
and EVAR repair was compared using log-rank analysis.
Patient characteristics between open and EVAR groups
were compared using 2 or the Fisher exact test for cate-
goric variables and the Student t test for continuous vari-
ables; data that were not normally distributed were ana-
lyzed using the Mann-Whitney rank sum test. Data are
expressed as the mean value  SD or as frequencies and
percentages. A value of P .05 was considered statistically
significant. Statistical analyses were performed with the use
of commercially available software (NCSS, Kaysville,
Utah).
RESULTS
Patient characteristics. Of the 677 patients who un-
derwent elective infrarenal AAA repair, 417 had conven-
tional open repair and 260 had EVAR. Demographic char-
acteristics and comorbidities of the patients are listed inTable I. Compared with the EVAR group, the patients
undergoing open repair were 3 years younger (71 vs 74
years, P .001) but had larger aneurysms (6.01  1.38 vs
5.45  0.99, P  .001), greater familial predisposition
(P  .039), and more current smokers (P  .011), which
likely contributed to more chronic obstructive pulmonary
disease (P  .001).
There were no differences in renal function, hyperten-
sion, coronary artery disease, or heart failure between the
two groups. The open repair group had 324 men (77.7%)
and 93women (22.3%), and the EVAR group had 207men
(79.6%) and 53 women (20.4%), with no differences in
gender distribution. Most patients in both groups were in
their eighth decade of life. The mean follow-up time was
1078  52 days for the EVAR group and 1665  41 days
for the open repair group (P  .0001).
Gender analysis. A significant gender difference was
found in our patient population with regards to age, with
women being 4 years older than men (75 vs 71 years, P 
.004) at the time of intervention. This observation persisted
for each treatment group. Women also presented with
smaller aneurysms (5.5 cm) than men (6.2 cm, P  .001).
Aneurysm specifics. Aneurysms were larger in the
open repair group (mean, 6.01 1.38 cm) compared with
the EVAR group (mean, 5.45 0.99 cm, P .001). In the
open repair group, both tube grafts and bifurcated grafts
were used as dictated by aneurysm morphology and sur-
geon preference. The devices used in the EVAR group were
183 Anurex, 24 Vangard, 15 Zenith, 12 Excluder, 9 An-
Cure, 7 Lifepath, 6 Baxter, and 4 Talent.
Operative mortality. Overall operative mortality was
3.1%. Operative mortality was 3.5% for the open repair
group and 2.7% for the EVAR group (P  .627; Table II).
A perceptible difference was found in operativemortality by
age (Table II). Only three patients 70 years died from
elective AAA repair (1.3%), and all had open repair. For
Table I. Demographics and comorbidities of abdominal
aortic aneurysm patients
Open* EVAR* P
Males 324 (77.7) 207 (79.6) .555
Females 93 (22.3) 53 (20.4) .555
Age (years) 71.6  7.9 73.7  7.6 .001
Aneurysm size (cm) 6.01  1.38 5.45  0.99 .001
Creatinine (mg/dL) 1.13  0.41 1.13  0.49 .642
Family history 39 (9.3) 13 (5) .039
Past smoker 227 (54.4) 165 (63) .027
Current smoker 134 (32.1) 60 (23.1) .011
COPD 170 (40.8) 50 (19.2) .001
Hypertension 293 (70.3) 178 (68.5) .620
CAD 203 (48.7) 141 (54.2) .160
CHF 38 (9.1) 35 (13.5) .076
COPD, Chronic obstructive pulmonary disease; CAD, coronary artery dis-
ease; CHF, congestive heart failure.
*Data are presented as n (%) for categoric variables and mean  standard
deviation for continuous variables, where appropriate.patients 80 years of age, operative mortality increased to
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(P  NS).
Other operative outcomes. Statistically significant
differences, all in favor of EVAR (Table III), were seen in
the amount of estimated blood loss (2532  1982 mL vs
536  708 mL, P  .001), length of stay (9  9.7 days vs
3.4 3.7 days, P .001), and patients discharged to home
(83% vs 95%, P  .001).
Mid-term and long-term survival. Operative mor-
tality was similar between the two treatment groups. Long-
term mortality at 1, 3, and 5 years for each group is shown
in Table IV. Only one aneurysm-related death in the cur-
rent series occurred after the postoperative period. An
overall Kaplan-Meier log-rank survival analysis showed no
difference between the two treatment groups (P  .20);
however, 2 analysis of the long-term mortality results
indicates that there was a mid-term (3-year) survival benefit
favoring open repair (P  .002; Fig 1). Since many believe
the benefit of EVAR may be greater in older patients, we
analyzed operative and long-term survival for patients70
years (Fig 2) and found no difference.
DISCUSSION
EVAR is rapidly developing as the technique of choice
for elective repair of infrarenal AAA. Although distinct
Table II. Operative mortality by decade of age
Age
Open
N (%)
Mortality
(%)
EVAR
N (%)
Mortality
(%)
40-49 3 (.8) 0 2 (.8) 0
50-59 27 (6.5) 0 3 (1.2) 0
60-69 121 (29) 3 (2.5) 71 (28) 0
70-79 203 (48) 5 (2.5) 124 (48) 3 (2.4)
80 63 (15) 6 (9.5) 60 (22) 4 (6.6)
Total 417 14 (3.5) 260 7 (2.7)
EVAR, Endovascular aneurysm repair.
Table III. Operative outcomes
Open,
n  417
EVAR,
n  260 P
Blood loss (mL) 2532  1982 536  708 .001
Length of stay (days) 9  9.7 3.4  3.7 .001
Discharged home (%) 345 (83) 245 (95) .001
EVAR, Endovascular aneurysm repair.
Table IV. Long-term mortality
Open,
n  417 (%)
EVAR,
n  260 (%)
1 year 28 (7) 23 (8.8)
3 year 40 (9.5) 41 (16)
5 year 65 (15) 41 (16)
EVAR, Endovascular abdominal aneurysm repair.short-term advantages to this less-invasive approach havebeen demonstrated,1,3 no definitive guidelines have been
established to determine which patients should undergo
EVAR vs open repair, assuming anatomy is appropriate for
both.
Procedure-related and long-term mortality are appro-
priately considered the primary focus for comparing these
two techniques. Although others have shown a significant
short-term survival benefit of EVAR,1,2,4 reducing opera-
tive mortality by up to 66%, that was not observed in this
clinical series. Interestingly, when EVAR demonstrated
benefit compared with open repair, themortality in patients
undergoing open repair approached 5%. If an operative
Fig 1. Kaplan-Meier survival curves for patients undergoing elec-
tive open repair and endovascular aneurysm repair (EVAR) for
infrarenal abdominal aortic aneurysms. Note that at 3 years, the
curves separate, demonstrating survival benefit in patients having
open repair. The curves later merge, showing equivalent survival at
5 years.
Fig 2. Kaplan-Meier survival curves of patients70 years under-
going elective open and endovascular aneurysm repair (EVAR) for
infrarenal abdominal aortic aneurysms.mortality of 4% can be achieved, it is likely that procedure-
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techniques. This point is illustrated by the current series in
which the mortality of open repair was substantially lower
than that observed in patients enrolled in randomized trials.
One cannot exclude clinical judgment and surgeon bias as
influencing results in any nonrandomized trial. Intuitively,
physician bias would seem to favorably affect open repair by
selecting higher-risk patients for EVAR. That did not ap-
pear to be the case in this series because, with the exception
of age, open repair patients had more comorbidities than
EVAR patients.
Trials reporting early survival benefit of EVAR have yet
to demonstrate a sustained survival advantage.1,2,4 Mortal-
ity results reported here are surprisingly similar to those
reported in the Lifeline registry. EVAR patients were older
than those undergoing open repair, women were older
than men, and women had smaller aneurysms than men.
Freedom from aneurysm-related rupture remained excel-
lent in both groups throughout follow-up. The survival
curves in our patients and in those of the Lifeline registry
(Fig 3) have a striking similarity. Although there is no
difference in procedure-related or long-term mortality,
there is a significant separation of mid-term (2.5-year to
3-year) mortality favoring those who have open repair. The
reasons for this observation are speculative, butmay include
more intense patient evaluation and better control of car-
diovascular risk factors over the mid-term in open repair
patients.
Operative mortality is usually associated with age and is
no different in this series. We were gratified to find that no
patient 60 years of age died as a result of elective opera-
tion for their AAA, and only three patients 70 years old
died. Although a much higher procedure-related mortality
occurred in patients 80 years (9.5% open, 6.5% EVAR),
the differences were not significant. Sicard et al5 reported
similar findings, with postoperative mortality no different
Fig 3. Kaplan-Meier life-table from the Lifeline registry superim-
posed upon the survival curves of the current series from Jobst
Vascular Center (JVC). Both show a mid-term (3-year) mortality
benefit of open repair. EVAR, Endovascular aneurysm repair.for open and EVAR groups. They also noted that thesubgroup of patients 80 years had an overall higher
mortality, but less so in patients undergoing EVAR.
Reduced procedure-related length of stay in the inten-
sive care unit and in the hospital is a consistent observation
of EVAR-treated patients compared with open repair.1,2,6
This advantage is muted by the increasing number of repeat
procedures over time in EVAR patients, which are associ-
ated with requisite hospitalization. Carpenter et al6 re-
ported that the procedure-related length-of-stay advantage
to EVAR was lost during the first year of follow-up owing
to the readmissions required for subsequent aneurysm-
related procedures. When total hospital days were com-
pared at 12 months, no difference existed between EVAR
and open repair patients. As follow-up continues over the
long term, the additional procedures required may actually
place EVAR patients at a disadvantage in a length-of-stay
analysis.
Patients undergoing EVAR have a significant reduction
in blood loss and the need for transfusions. Translating the
short-term benefit into a long-term advantage relates to the
risk of blood-borne diseases. This risk in the United States
is miniscule compared with other comorbidities facing pa-
tients and is unlikely to translate into meaningful clinical
observations.
CONCLUSION
Open repair and EVAR can both be performed safely in
patients treated for elective infrarenal AAA. Owing to the
low operative mortality of open repair in patients70 years
old, open repair should be liberally applied in younger
patients with AAA. EVAR clearly has perioperative advan-
tages of reduced blood loss, decreased length of hospital
stay, and an increased number of patients discharged to
home. Early and late survival curves are similar; however,
the long-term follow-up in EVAR patients is limited. The
midterm survival advantage in open repair patients noted
here and in other reports deserves greater study. If specific
factors can be identified that correlate with this midterm
survival advantage, perhaps improved survival over the long
term can be enjoyed by both treatment groups.
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Chahwan and colleagues have provided a valuable analysis of
their single-center experience with abdominal aortic aneurysm
(AAA) repair. Their review analyzes the short-term and intermedi-
ate-term results of standard open repair and endovascular repair
(EVAR) performed using a wide variety of stent grafts and high-
lights several important areas that are of interest. Of particular
note, the authors are to be congratulated on obtaining excellent
results—particularly with open AAA repair—where they achieved a
mortality rate of 3.5% compared with 2.7% for EVAR (P  NS).
With this low perioperative mortality rate for open repair and
the relatively small sample size, the authors were able to negate any
significant perioperative survival advantage for EVAR. This mirrors
the results of the pivotal trials reported for the AneuRx1
(Medtronic, Minneapolis, Minn), Excluder,2 (W.L. Gore and As-
sociates, Flagstaff, Ariz) and Zenith3 (Cook, Bloomington, Ind)
devices. Only in studies that evaluated much larger patient popu-
lations could significantly lower perioperative mortality be demon-
strated for endovascular repair.4
The current study did demonstrate significant advantages with
respect to operative blood loss and hospital length of stay, again
similar to the previously reported pivotal trials. These findings rein-
force previously published analyses that indicate success in preventing
aneurysm-related death can be achieved in appropriately selected
patients using conventional open repair techniques. The increase in
perioperativemorbidity associated with open repair may ultimately be
balanced by its increased durability. This is suggested by the authors’
finding of increased survival at the 3-year time point. Although this
could not be related to increased aneurysm-related mortality in the
EVARgroup, and the overall survival curves did not vary significantly,
the finding is interesting. Whether it implies the patients who under-
went open repair receivedmore thoroughmanagement of cardiac and
other comorbid medical conditions or another more difficult-to-
define cause cannot be determined from the current study.
The distribution of open and endovascular repair procedures is
also interesting. In this population, considerably more patients
were treated with open repair (n  417) than with EVAR (n 
260). This appears to be in distinction tomost published series, but
may be a more accurate reflection of general practice during the
decade being studied. The authors do note a trend toward increas-
ing use of EVAR in their patient population. This has resulted in
longer follow-up for patients treated by standard open repair. It is
difficult to determine if this influenced the reported rates for
reintervention because these are not analyzed by the type of repairOf concern in the analysis is the selection of the type of repair
procedure performed. Although the authors suggest that they
favored open repair for patients who were generally younger (on
average 71 vs 74 years old), the patients treated with open repair
did not appear to have an increased number of comorbid medical
conditions. Whether this reflects a limitation of the analysis of
comorbid factors that limits the ability to distinguish the extent of
the comorbid disease or whether it is an accurate reflection of a
truly equal distribution of disease between the two groups cannot
be distinguished in the current analysis.
It is also interesting that average size of the aneurysms treated
by standard open repair was significantly larger (6.0 cm) than the
size of aneurysms treated using EVAR (5.4 cm). It is possible that
the authors have different thresholds for performing aneurysm
repair according to the technique that is going to be used. For
patients in whom open repair is being considered, the threshold for
repair with respect to maximum aortic diameter may be higher.
Alternatively, larger aneurysms may not have anatomy suitable for
endovascular repair and consequently open repair is necessary.
Ultimately, the equivalent survival curves between the open
and endovascular repair groups suggest that patients can undergo
EVAR and thereby reduce the perioperative blood loss, hospital
length of stay, and recovery time, and still maintain longer-term
survival that is equal to patients treated by open repair. This
appears to be of particular relevance for octogenarians, in whom
the increase in perioperative mortality for open repair appears to be
most significant.
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